Pediatrics – Pulmonology
#CCR22 – RCT: High-flow nasal cannula therapy met criteria for noninferiority compared to CPAP for the liberation from respiratory support in acutely ill children in the ICU.
16 Jun, 2022 | 11:10h | UTCEffect of High-Flow Nasal Cannula Therapy vs Continuous Positive Airway Pressure Therapy on Liberation From Respiratory Support in Acutely Ill Children Admitted to Pediatric Critical Care Units: A Randomized Clinical Trial – JAMA (free for a limited period)
Commentary on Twitter
Among acutely ill children clinically assessed to require noninvasive respiratory support in a pediatric critical care unit, HFNC met the criterion for noninferiority compared with CPAP for time to liberation from respiratory support. https://t.co/WvU2fKLDOJ #CCR22
— JAMA (@JAMA_current) June 16, 2022
RCT: Effect of point-of-care testing for respiratory pathogens on antibiotic use in children.
10 Jun, 2022 | 11:16h | UTC
Commentary on Twitter
In a randomized controlled trial of 1243 children, point-of-care testing for respiratory pathogens did not reduce antibiotic consumption in acutely ill children. https://t.co/KnD4zRx2bf
— JAMA Network Open (@JAMANetworkOpen) June 9, 2022
RCT: The effect of azithromycin on structural lung disease in infants with cystic fibrosis.
7 Jun, 2022 | 11:29h | UTCThe effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial – The Lancet Respiratory Medicine (link to abstract – $ for full-text)
Systematic Review: Positioning for acute respiratory distress in hospitalized infants and children.
7 Jun, 2022 | 11:17h | UTCPositioning for acute respiratory distress in hospitalised infants and children – Cochrane Library
Summary: Positioning for hospitalised infants and children with acute respiratory distress
M-A: Prevalence of respiratory viruses in community-acquired pneumonia in children.
1 Jun, 2022 | 10:57h | UTCPrevalence of respiratory viruses in community-acquired pneumonia in children: a systematic review and meta-analysis – The Lancet Child & Adolescent Health (link to abstract – $ for full-text)
Commentary on Twitter
#Respiratory viruses are frequently detected in community-acquired #pneumonia among #children of all ages and geographical regions. Most common viruses were #RSV (23%) and #rhinovirus (22%) in the pre-COVID years
New Research by @MejbahBhuiyan & team: https://t.co/4ph2Isotcu
— The Lancet Child & Adolescent Health (@LancetChildAdol) May 31, 2022
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019.
27 May, 2022 | 12:15h | UTCCommentaries:
Need for improved global measurement of early childhood respiratory syncytial virus disease – The Lancet (free registration required)
RSV kills 100,000 kids under age 5 a year worldwide – CHEST Physician
Systematic Review: Airway complications resulting from pediatric esophageal button battery impaction.
27 May, 2022 | 11:49h | UTCAirway Complications Resulting From Pediatric Esophageal Button Battery Impaction: A Systematic Review – JAMA Otolaryngology-Head & Neck Surgery (free for a limited period)
Invited Commentary: Pediatric Button Battery Injuries—Current State and What’s Next? – JAMA Otolaryngology-Head & Neck Surgery
Modeling Study: 20% of multi-drug resistant tuberculosis cases in children could be averted by household testing and treatment.
25 May, 2022 | 10:44h | UTCInvited Commentary: Investing in drug-resistant tuberculosis household contact management and preventive treatment – The Lancet Global Health
Study Commentary | Antibiotics for pediatric pneumonia: might less be enough?
17 May, 2022 | 10:39h | UTCAntibiotics for Pediatric Pneumonia: Might Less Be Enough? – Annals of Emergency Medicine
Related:
Treatment of UTIs in Infants <2 Months: A Living Systematic Review – Hospital Pediatrics
Interstitial lung disease in infancy and early childhood: a clinicopathological primer.
12 May, 2022 | 07:54h | UTC
Preventing asthma deaths in school children: 3 things to know.
4 May, 2022 | 10:59h | UTCPreventing asthma deaths in school children: 3 things to know – Evidently Cochrane
Related video: Preventable
Commentary on Twitter
Deaths from #asthma are the highest they've been in a decade. GP @RobincarrCarr explains 3 things that can reduce this risk in school children: https://t.co/CDvaC4grZk
+ watch 'Preventable', a film on preventing asthma deaths in schools: https://t.co/waARmT5Mz2 @CochraneAirways
— Cochrane UK (@CochraneUK) May 3, 2022
Review: Mechanical ventilation in pediatric and neonatal patients.
4 May, 2022 | 10:29h | UTCMechanical Ventilation in Pediatric and Neonatal Patients – Frontiers in Physiology
RCT: Nasal high-flow therapy during neonatal endotracheal intubation.
28 Apr, 2022 | 08:07h | UTCNasal High-Flow Therapy during Neonatal Endotracheal Intubation – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Successful Intubations Up With Nasal High-Flow Therapy in Neonates – HealthDay
Commentary on Twitter
Nasal high-flow therapy during neonatal endotracheal intubation increased the likelihood of successful intubation on the first attempt without physiological instability. https://t.co/JWRgtAcoAN pic.twitter.com/EQdFW6pojF
— NEJM (@NEJM) April 27, 2022
RCT: Noninvasive high-frequency oscillatory ventilation vs. nasal continuous positive airway pressure vs. nasal intermittent positive pressure ventilation as postextubation support for preterm neonates.
27 Apr, 2022 | 07:59h | UTCNoninvasive High-Frequency Oscillatory Ventilation vs Nasal Continuous Positive Airway Pressure vs Nasal Intermittent Positive Pressure Ventilation as Postextubation Support for Preterm Neonates in China: A Randomized Clinical Trial – JAMA Pediatrics (free for a limited period)
Commentaries on Twitter
In this randomized clinical trial, NHFOV and nasal intermittent positive pressure ventilation in neonates provided a small advantage of reduced need for invasive respiratory support when used from extubation and until discharge. https://t.co/qCtNP8Gwj9
— JAMA Pediatrics (@JAMAPediatrics) April 25, 2022
A RCT in @JAMAPediatrics evaluates total duration of mechanical ventilation, need for reintubation, and ventilator-free days after extubation to either NHFOV, NCPAP or NIPPV. https://t.co/krwwMv2Hbr#EBNEOalerts #neoEBM #neotwitter pic.twitter.com/uenwdlZfO4
— Evidence-Based Neo (@EBNEO) April 27, 2022
Systematic Review: Continuous positive airway pressure (CPAP) for acute bronchiolitis in children.
20 Apr, 2022 | 09:02h | UTCContinuous positive airway pressure (CPAP) for acute bronchiolitis in children – Cochrane Library
Summary: Continuous positive airway pressure (CPAP) for acute bronchiolitis in children – Cochrane Library
Study showed low rates of severe COVID-19 in children hospitalized with confirmed SARS-CoV-2 infection.
14 Apr, 2022 | 08:49h | UTCCommentary: Severe COVID-19 extremely rare among children – News Medical
Related:
COVID-19 disease severity in children infected with the Omicron variant.
Study identifies risk factors for severe CoviD-19 in children.
International study identifies predictors of severe outcomes in children with COVID-19.
RCT: In critically ill children requiring noninvasive respiratory support following extubation, high-flow nasal cannula therapy was NOT noninferior to CPAP, resulting in increased time to liberation from respiratory support.
8 Apr, 2022 | 11:07h | UTCEffect of High-Flow Nasal Cannula Therapy vs Continuous Positive Airway Pressure Following Extubation on Liberation From Respiratory Support in Critically Ill Children: A Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: Selecting Intermediate Respiratory Support Following Extubation in the Pediatric Intensive Care Unit – JAMA (free for a limited period)
News Release: Trial identifies most effective breathing support for children in intensive care – Imperial College London
Commentary on Twitter
In this study, among critically ill children requiring noninvasive respiratory support following extubation, HFNC vs CPAP failed to meet the criterion for noninferiority for time to liberation from respiratory support. https://t.co/X1lNAO28le #CCR pic.twitter.com/XBnUpsqUNq
— JAMA (@JAMA_current) April 7, 2022
Long COVID in children: a modified Delphi process.
8 Apr, 2022 | 10:40h | UTCRelated:
First research definition for ‘Long COVID’ in kids and young people formally agreed.
Editorial | Long covid in children and adolescents – “Risk appears low, but many questions remain”.
Review: Long COVID symptoms in children rarely persist beyond three months.
Review: Understanding pediatric ventilation in the operative setting.
6 Apr, 2022 | 08:42h | UTCPart I: Physical principles of monitoring in the modern anesthesia workstation – Pediatric Anesthesia
Part II: Setting perioperative ventilation – Pediatric Anesthesia
Review: Developmental respiratory physiology.
6 Apr, 2022 | 08:41h | UTCDevelopmental respiratory physiology – Pediatric Anesthesia
Update on ventilatory management of extremely preterm infants—A Neonatal Intensive Care Unit perspective.
6 Apr, 2022 | 08:40h | UTC
Review: Novel ventilation techniques in children.
6 Apr, 2022 | 08:38h | UTCNovel ventilation techniques in children – Pediatric Anesthesia
Cluster RCT: Co-ordinated multidisciplinary intervention to reduce time to successful extubation for children on mechanical ventilation.
1 Apr, 2022 | 10:01h | UTCDownload: Full Report
Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study in England.
31 Mar, 2022 | 08:29h | UTCInvited Commentary: Importance of understanding the reinfection risk of COVID-19 in children – The Lancet Child & Adolescent Health
Commentary on Twitter
Everything we know about #SARSCoV2 tells us that first infection reduces (but doesn’t eliminate) the risk & SEVERITY of further infections, even with new variants. Here is our paper showing this with delta reinfections in kids (work on omicron reinfections in progress)? https://t.co/3gDPBHRu18
— Shamez Ladhani (@ShamezLadhani) March 30, 2022
RCT: Among premature infants with a gestational age of less than 30 weeks and intubated for at least 7 days at 14 to 28 days, hydrocortisone did not improve survival without bronchopulmonary dysplasia.
24 Mar, 2022 | 09:58h | UTCHydrocortisone to Improve Survival without Bronchopulmonary Dysplasia – New England Journal of Medicine (link to abstract – $ for full-text)
See also: Visual Abstract
Related:
State of the Art Review: Diagnosis and management of bronchopulmonary dysplasia.
ERS Guideline on Long-term Management of Children with Bronchopulmonary Dysplasia
Commentary on Twitter
In this trial involving preterm infants, there was little difference in survival without bronchopulmonary dysplasia or in the occurrence of neurodevelopmental impairment with hydrocortisone as compared with placebo. https://t.co/wzGQ1gohjA pic.twitter.com/yfrIaG3JLv
— NEJM (@NEJM) March 23, 2022